Pr Thomas Decaens
- Specialty
- Oncologist, liver expert
- Title
- Head of service
- Hospital
- Centre Hospitalier Université Grenoble Alpes (Grenoble)
- Latest articles
-
- Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy. (Sep 1, 2025)
- A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data. (Aug 1, 2025)
- Alcohol Consumption After Listing for Liver Transplantation Is Associated With Increased Risk of Alcohol Consumption After Transplantation. (Jun 26, 2025)
- Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial. (May 24, 2025)
- Hypothermic Oxygenated Machine Perfusion and Static Cold Storage Drive Distinct Immunomodulation During Liver Transplantation: A Pilot Study. (Apr 1, 2025)